Application of “Cloud Pharmaceutical Service System” in the medication therapy management for chronic airway diseases

SHI Yinping; LIU Xue; WANG Xiangqian; DUAN Sai; LI Yan; HUANG Xin; YANG Rui

doi:10.6039/j.issn.1001-0408.2023.07.21

您当前的位置：

首页 >

文章列表页 >

Application of “Cloud Pharmaceutical Service System” in the medication therapy management for chronic airway diseases

更新时间：2024-02-19

- Application of “Cloud Pharmaceutical Service System” in the medication therapy management for chronic airway diseases
- ZHONGGUO YAOFANG Vol. 34, Issue 7, Pages: 878-882(2023)
- 作者机构：
  
  山东第一医科大学第一附属医院（山东省千佛山医院）临床药学科/山东省儿童药物临床评价与研发工程技术研究中心/山东省医药卫生临床药学重点实验室，济南　250014
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2023.07.21
  CLC： R969.3
- Published：15 April 2023，
  
  Received：31 July 2022，
  
  Revised：02 February 2023，
扫描看全文
时银萍,刘雪,王向前等.“云药事服务系统”在慢性气道疾病药物治疗管理中的应用 ^Δ[J].中国药房,2023,34(07):878-882.

SHI Yinping,LIU Xue,WANG Xiangqian,et al.Application of “Cloud Pharmaceutical Service System” in the medication therapy management for chronic airway diseases[J].ZHONGGUO YAOFANG,2023,34(07):878-882.
时银萍,刘雪,王向前等.“云药事服务系统”在慢性气道疾病药物治疗管理中的应用 ^Δ[J].中国药房,2023,34(07):878-882. DOI： 10.6039/j.issn.1001-0408.2023.07.21.

SHI Yinping,LIU Xue,WANG Xiangqian,et al.Application of “Cloud Pharmaceutical Service System” in the medication therapy management for chronic airway diseases[J].ZHONGGUO YAOFANG,2023,34(07):878-882. DOI： 10.6039/j.issn.1001-0408.2023.07.21.

摘要

目的

评价“云药事服务系统”电子化管理平台在慢性气道疾病药物治疗管理（MTM）中的应用效果。

方法

介绍“云药事服务系统”MTM模块设置情况；选取2021年1月－2022年3月就诊于我院的慢性气道疾病患者371例，应用该系统对其进行MTM，分别采用自制的吸入装置评估量表、Morisky服药依从性量表（MMAS-8）评分比较干预前后患者对吸入装置的使用规范性和用药依从性，并调查干预后患者对药师的满意度。

结果

“云药事服务系统”主要分为药物治疗评估、药师干预、个人用药记录和药物治疗相关的行动计划制定、其他功能4个模块。371例患者中，门诊患者有237例（包括支气管哮喘142例、慢性阻塞性肺疾病95例），住院患者有134例（包括支气管哮喘19例、慢性阻塞性肺疾病115例）。患者吸入装置评估量表得分由干预前的（74.76±24.71）分提高至干预后的（99.45±2.12）分（

＜0.05）；MMAS-8评分由干预前的（7.14±1.15）分提高至干预后的（7.88±0.44）分（

＜0.05）；干预后患者对药师的满意度达到了100%。

结论

“云药事服务系统”可提供全程化、线上、可视、及时的MTM，有助于提升对慢性气道疾病患者的药学服务效果。

Abstract

OBJECTIVE

To evaluate the effect of “Cloud Pharmacy Service System” electronic management platform in medication therapy management （MTM） of chronic airway diseases.

METHODS

MTM module setting of “Cloud Pharmaceutical Service System” was introduced. Totally 371 patients with chronic airway disease admitted to our hospital from January 2021 to March 2022 were selected for MTM based on the “Cloud Pharmacy Service System”. The standardization of inhalation device mastery and compliance of patients before and after intervention were compared with self-made inhalation device evaluation scale and Morisky medication adherence scale-8 （MMAS-8）. The satisfaction of patients with pharmacist after intervention was investigated.

RESULTS

“Cloud Pharmaceutical Service System” is mainly divided into 4 modules， such as medication therapy review， pharmacist intervention， personal medication record and the medication-related action plan， other functions. Among 371 patients， there were 237 outpatients （142 cases of asthma， 95 cases of chronic obstructive pulmonary disease） and 134 inpatients （19 cases of asthma and 115 cases of chronic obstructive pulmonary disease）. The score of the patients using inhalation device increased from 74.76±24.71 before intervention to 99.45±2.12 after intervention （

＜0.05）. MMAS-8 score increased from 7.14±1.15 before intervention to 7.88±0.44 after intervention （

＜0.05）. The degree of patients’ satisfaction with pharmacists reached 100% after intervention.

CONCLUSIONS

“Cloud Pharmacy Service System” is helpful to improve the effects of pharmaceutical service for patients with chronic airway disease by providing whole-process， online， visual and immediate MTM.

关键词

云药事服务系统；慢性气道疾病；药物治疗管理；药学服务

Keywords

chronic airway diseasesmedication therapy managementpharmaceutical care

references

WANG C，XU J Y，YANG L，et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China （the China Pulmonary Health [CPH] study）：a national cross-sectional study[J]. Lancet，2018，391（10131）：1706-1717.

HUANG K W，YANG T，XU J Y，et al. Prevalence，risk factors，and management of asthma in China：a national cross-sectional study[J]. Lancet，2019，394（10196）：407-418.

中国医学装备协会呼吸病学专委会吸入治疗与呼吸康复学组，中国慢性阻塞性肺疾病联盟. 稳定期慢性气道疾病吸入装置规范应用中国专家共识[J]. 中华结核和呼吸杂志，2019，42（4）：241-253.

CIPOLLE R J，STRAND L M ，MORLEY P C. 药学监护实践方法：以患者为中心的药物治疗管理服务[M]. 康震，金有豫，朱珠，等译. 北京：化学工业出版社，2016：2-5.

JARAB A S，AL-QEREM W，MUKATTASH T L，et al. Pharmacists’ knowledge and attitudes toward medication therapy management service and the associated challenges and barriers for its implementation[J]. Saudi Pharm J，2022，30（6）：842-848.

GRANT J J，MCDADE E J，ZOBELL J T，et al. The indi- spensable role of pharmacy services and medication therapy management in cystic fibrosis[J]. Pediatr Pul- monol，2022，57（Suppl 1）：S17-S39.

中华医学会呼吸病学分会慢性阻塞性肺疾病学组，中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会.慢性阻塞性肺疾病诊治指南：2021年修订版[J].中华结核和呼吸杂志，2021，44（3）：170-205.

中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南：2020年版[J].中华结核和呼吸杂志，2020，43（12）：1023-1048.

王可，侯凯旋，闫素英. 国内外药物治疗管理开展现状[J]. 中国药房，2018，29（5）：580-586.

林茂，陈哲，曾力楠，等. 国内、外药物治疗管理文献研究现状分析[J]. 中国药房，2019，30（17）：2305-2310.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

No data

Related Author

No data

Related Institution

No data

Address：8/F,129 Daping Main Street,Yuzhong District,Chongqing 400042,P.R.China
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰